FindTrial
Sign In

15&#45

2 trials

Sponsors

Navamindradhiraj University, Center of Excellence for Pediatric Infectious Diseases and Vaccines

Conditions

Multi-drug resistant tuberculosis Isoniazid resistant tuberculosis patient with toxicity from the first line antituberculosis MDR-TB Hr-TB Toxicity from the first line anti-TB Levofloxacinnumber of glomeruli adequate of tissue bleeding complication non patholgical diagnosis tissue kidney biopsy ultrasound guide blind real time

Phase 3

The Efficacy of Blind versus Real-Time Ultrasound-guided Percutaneous Renal Biopsy
Active, not recruitingTCTR20181024002
Navamindradhiraj Universitynumber of glomeruli adequate of tissue bleeding complication non patholgical diagnosis tissue kidney biopsy ultrasound guide blind real time
Start: 2018-10-18Target: 200Updated: 2026-08-03

Phase 4

Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study
Active, not recruitingTCTR20190515001
Center of Excellence for Pediatric Infectious Diseases and VaccinesMulti-drug resistant tuberculosis Isoniazid resistant tuberculosis patient with toxicity from the first line antituberculosis MDR-TB Hr-TB Toxicity from the first line anti-TB Levofloxacin
Start: 2019-06-01Target: 20Updated: 2026-08-03